N@N

ROX, CPRX, OICO, AFFM, MNOV Expected To Be Lower After Earnings Releases on Monday

^{Published on 2010-08-13 07:07:59, Last Modified on 2010-12-22 18:46:14 - WOPRAI}
 

August 13, 2010 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Monday, August 16th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and August earnings reports. Castle Brands (NYSE: ROX), Catalyst Pharmaceutical Partners (NASDAQ: CPRX), OI Corp (NASDAQ: OICO), Affirmative Insurance Holdings (NASDAQ: AFFM) and MediciNova (NASDAQ: MNOV) are all expected to be lower after their earnings are released Monday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go lower after earnings are released Monday:

Symbol Company # of Reports Quarter Release Time

ROX Castle Brands Inc. 12 quarters Q1 After

CPRX Catalyst Pharmaceutical 12 quarters Q2 Before

OICO OI Corp. August earnings Q2 During

AFFM Affirmative Insurance 12 quarters Q2 During

MNOV MediciNova Inc. 12 quarters Q2 After

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Castle Brands Inc. (NYSE: ROX) engages in the development, importation, marketing, and sale of vodka, whiskey, rums, tequila, liqueurs, and wines in the United States, Canada, Europe, Latin America and the Caribbean. The company markets various brands, including the Gosling's Rum, Jeffersona�s bourbons, Clontarf Irish whiskeys, Knappogue Castle Whiskey, Knappogue Castle 1951, Pallini liqueurs, Boru vodka, Tierras tequila, Bradya�s Irish cream liqueur, and Betts & Scholl wines, as well as Jeffersona�s Reserve and Jeffersona�s Presidential Select bourbons. It sells products through wholesale distributors and beverage alcohol control agencies in the United States; and directly to retail establishments, including liquor stores, chain stores, restaurants, and pubs internationally. The company has a joint venture with Drink Pie, LLC to manage the manufacture and marketing of Travis Hasse's Original(R) Apple Pie Liqueur and Cherry Pie Liqueur. Castle Brands Inc. is based in New York, New York.

Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX), a development-stage biopharmaceutical company, focuses on the development and commercialization of prescription drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy. It is evaluating its lead product candidate, CPP-109, a GABA aminotransferase inhibitor, which is under Phase II(b) clinical trial for the treatment of cocaine addiction, as well as focuses on evaluating CPP-109 for the treatment of other addictions and obsessive-compulsive disorders. The company is also developing CPP-115, a GABA aminotransferase inhibitor for various indications, including epilepsy and drug addiction. It has license agreements with Brookhaven Science Associates, LLC on various patents and patent applications relating to the use of vigabatrin as a treatment for cocaine and other addictions, and obsessive-compulsive disorders; and with Northwestern University to commercialize GABA aminotransferase inhibitors worldwide. Catalyst Pharmaceutical Partners, Inc. was founded in 2002 and is based in Coral Gables, Florida.

O.I. Corporation (NASDAQ: OICO), doing business as OI Analytical, designs and manufactures analytical, monitoring, and sample preparation products, components, and systems used to detect, measure, and analyze chemical compounds in air and water. The company offers laboratory products, including gas chromatography instruments and systems to separate organic compounds based on their physical and chemical properties; total organic carbon analyzer systems and related accessories to measure organic and inorganic carbon levels in ultrapure, drinking, natural, ground, waste, and process water, as well as soils and solids; automated chemistry analyzers, such as segmented flow and flow injection analyzers to perform various ion analyses, including the measurement of nitrate, nitrite, phosphate, ammonia, chloride, alkalinity, and sulfate in liquids; sample preparation products and systems to prepare sample matrices for analysis; and specific air monitors, which employ infrared based analyzers to monitor and detect low-level refrigerant leaks. The company also offers MINICAMS air-monitoring systems to monitor air for toxic chemical compounds, including gaseous chemical-warfare agents, such as mustard, sarin, and lewisite to address air-monitoring levels. In addition, O.I. Corporation provides on-site installation and support services. It serves environmental testing, food and flavors, pharmaceutical, semiconductor, power generation, chemical, petrochemical, and security industries, as well as various military agencies of the U.S. Government, engineering and consulting firms, municipalities, and chiller-refrigerant companies. O.I. Corporation sells its products through a direct sales force, as well as through independent sales representatives and distributors. The company was formerly known as Oceanography International Corporation and changed its name to O.I. Corporation in July 1980. O.I. Corporation was founded in 1963 and is headquartered in College Station, Texas.

Affirmative Insurance Holdings, Inc. (NASDAQ: AFFM), through its subsidiaries, operates as a distributor and producer of non-standard personal automobile insurance policies and related products and services for individual consumers in the United States. It offers liability-only policies that comprise bodily injury liability coverage, property damage liability coverage, and personal injury protection coverage and/or medical payment coverage. The company also provides full coverage policies, which include collision coverage for damage to the insured vehicle as a result of a collision with another vehicle or object; comprehensive coverage for damages to the insured vehicle as a result of theft, hail, and vandalism; and optional coverages, such as towing, rental reimbursement, and special equipment. In addition, it sells third-party non-standard personal automobile insurance policies; and complementary insurance products, including motorcycle and recreational vehicle coverage, motor club memberships, vehicle protection, travel protection, and hospital indemnity, as well as non-insurance products and services, such as towing, hospital indemnity insurance, and income tax services. The company distributes its products through independent agents or brokers, unaffiliated underwriting agencies, retail stores, virtual call center, and Internet, as well as through a premium finance company. As of December 31, 2009, it owned 201 retail stores. The company, formerly known as Instant Insurance Holdings, Inc., was founded in 1998 and is based in Addison, Texas.

MediciNova, Inc. (NASDAQ: MNOV), a biopharmaceutical company, engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs principally in the United States. The companya�s development pipeline includes programs that are in clinical development for the treatment of asthma, acute exacerbations of asthma, multiple sclerosis, central nervous system disorders, interstitial cystitis, solid tumor cancers, generalized anxiety disorder/insomnia, preterm labor, and urinary incontinence. Its principal product development programs consist of MN-221, which completed Phase II clinical trial for the treatment of acute exacerbations of asthma, and completed Phase Ib clinical trial for the treatment of chronic obstructive pulmonary disease; MN-166 that has completed Phase II clinical trial for the treatment of multiple sclerosis; and AV411, which has advanced through multiple Phase I and IIa clinical trials for the treatment of central nervous system disorders. The companya�s other product development programs include MN-001, which completed Phase II/III clinical trial for the treatment of interstitial cystitis and an oral dosing formulation prototype for the treatment of bronchial asthma; MN-029 that completed Phase I clinical trial for the treatment of solid tumors; MN-305, which completed Phase II/III clinical trial for the treatment of generalized anxiety disorder and Phase II clinical trial for the treatment of insomnia; MN-221 that completed a Phase I clinical trial for the treatment of preterm labor; and MN-246, a Phase I clinical trial completed product for the treatment of urinary incontinence. Its preclinical development products comprise MN-447 and MN-462 for the treatment of thrombotic disorders. The company was founded in 2000 and is headquartered in San Diego, California.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641